Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2004 2
2005 1
2006 2
2007 3
2008 4
2009 6
2010 3
2011 6
2012 5
2013 3
2014 8
2015 5
2016 4
2017 6
2018 3
2019 5
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
Definition and management of radioactive iodine-refractory differentiated thyroid cancer.
Schlumberger M, Brose M, Elisei R, Leboulleux S, Luster M, Pitoia F, Pacini F. Schlumberger M, et al. Among authors: pitoia f. Lancet Diabetes Endocrinol. 2014 May;2(5):356-8. doi: 10.1016/S2213-8587(13)70215-8. Epub 2014 Jan 30. Lancet Diabetes Endocrinol. 2014. PMID: 24795243 No abstract available.
Rare complications of multikinase inhibitor treatment.
Pitoia F, Schmidt A, Bueno F, Abelleira E, Jerkovich F. Pitoia F, et al. Arch Endocrinol Metab. 2018;62(6):636-640. doi: 10.20945/2359-3997000000090. Arch Endocrinol Metab. 2018. PMID: 30624504
Dynamic risk assessment in patients with differentiated thyroid cancer.
Pitoia F, Jerkovich F. Pitoia F, et al. Endocr Relat Cancer. 2019 Oct;26(10):R553-R566. doi: 10.1530/ERC-19-0213. Endocr Relat Cancer. 2019. PMID: 31394499 Review.
Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation.
Schmidt A, Iglesias L, Klain M, Pitoia F, Schlumberger MJ. Schmidt A, et al. Among authors: pitoia f. Arch Endocrinol Metab. 2017 Jan-Feb;61(1):81-89. doi: 10.1590/2359-3997000000245. Epub 2017 Feb 13. Arch Endocrinol Metab. 2017. PMID: 28225999 Review.
Selective use of sorafenib in the treatment of thyroid cancer.
Pitoia F, Jerkovich F. Pitoia F, et al. Drug Des Devel Ther. 2016 Mar 11;10:1119-31. doi: 10.2147/DDDT.S82972. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27042004 Free PMC article. Review.
Unusual metastases from differentiated thyroid carcinoma: analysis of 36 cases.
Zunino A, Pitoia F, Faure E, Reyes A, Sala M, Sklate R, Ilera V, Califano I; Thyroid Department of Sociedad Argentina de Endocrinología y Metabolismo. Zunino A, et al. Among authors: pitoia f. Endocrine. 2019 Sep;65(3):630-636. doi: 10.1007/s12020-019-01991-0. Epub 2019 Jul 20. Endocrine. 2019. PMID: 31327159
Outcomes of patients with bone metastases from differentiated thyroid cancer.
Califano I, Deutsch S, Löwenstein A, Cabezón C, Pitoia F. Califano I, et al. Among authors: pitoia f. Arch Endocrinol Metab. 2018 Feb;62(1):14-20. doi: 10.20945/2359-3997000000004. Arch Endocrinol Metab. 2018. PMID: 29694635
Thyroid cancer in the Era of COVID-19.
Smulever A, Abelleira E, Bueno F, Pitoia F. Smulever A, et al. Among authors: pitoia f. Endocrine. 2020 Oct;70(1):1-5. doi: 10.1007/s12020-020-02439-6. Epub 2020 Aug 4. Endocrine. 2020. PMID: 32754886 Free PMC article. Review.
Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer.
Bueno F, Falcone MGG, Peñaloza MA, Abelleira E, Pitoia F. Bueno F, et al. Among authors: pitoia f. Endocrine. 2020 Feb;67(2):387-396. doi: 10.1007/s12020-019-02112-7. Epub 2019 Oct 24. Endocrine. 2020. PMID: 31650394
The "broken chair" in patients with differentiated thyroid cancer.
La Greca A, Pitoia F, Tuttle RM. La Greca A, et al. Among authors: pitoia f. Endocrine. 2017 Aug;57(2):359-360. doi: 10.1007/s12020-017-1345-y. Epub 2017 Jun 14. Endocrine. 2017. PMID: 28616850 No abstract available.
75 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback